Skip to content
User

Nicolai Tangen

AKO Capital

Nicolai Tangen Procter & Gamble Company stake

total: 72

AKO Capital PG trades

Total transactions:
26
New positions:
1
Sold out:
1
Added:
13
Reduced:
11
Held since:
2018 Q4
Held for:
25 quarters
Latest activity:
2025 Q1
According to 2026 Q2 report, Nicolai Tangen doesn't hold any Procter & Gamble Company (PG) shares. To date, the estimated cost basis is nearly $124.43 for "buy" trades and estimated average "sell" price is $150.96. AKO Capital first purchased PG in 2018 Q4, initially acquiring 798,918 shares. Since the initial investment in Procter & Gamble Company (PG), AKO Capital has made 25 more transactions.

When did Nicolai Tangen sell Procter & Gamble Company (PG)?

Nicolai Tangen sold off the entire Procter & Gamble Company (PG) position in 2025 Q1.

When did Nicolai Tangen buy Procter & Gamble Company (PG)?

Nicolai Tangen first invested in Procter & Gamble Company (PG) in 2018 Q4 at the reported quarter-end price of $91.92 per share.

What's the cost basis of AKO Capital's PG stake?

The estimated cost basis for Procter & Gamble Company (PG) stake is around $124.43 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$124.43
Weighted AVG sell price:
$150.96

Nicolai Tangen's historical trades in Procter & Gamble Company

26 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2025 Q1
0.00%
0
$167.65
-100% (-1,172,423)
-2.72%
2024 Q4
2.72%
1,172,423
$167.65
$196,557,000
+10.81% (+114,397)
+0.27%
2024 Q3
2.39%
1,058,026
$173.20
$183,250,000
-0.27% (-2,858)
-0.01%
2024 Q2
2.40%
1,060,884
$164.92
$174,961,000
+4.73% (+47,925)
+0.11%
2024 Q1
2.33%
1,012,959
$162.25
$164,353,000
+28.88% (+226,994)
+0.52%
2023 Q4
1.64%
785,965
$146.54
$115,175,000
-14.75% (-135,981)
-0.33%
2023 Q3
2.19%
921,946
$145.86
$134,475,000
-1.87% (-17,596)
-0.04%
2023 Q2
2.16%
939,542
$151.74
$142,566,000
-4.29% (-42,153)
-0.1%
2023 Q1
2.22%
981,695
$148.69
$145,968,000
-4.37% (-44,855)
-0.11%
2022 Q4
2.51%
1,026,550
$151.56
$155,584,000
-3.39% (-36,048)
-0.09%
2022 Q3
2.21%
$126.25
-11.72% (-141,033)
2022 Q2
2.42%
$143.79
-38.69% (-759,400)
2022 Q1
3.24%
$152.80
-21.61% (-541,187)
2021 Q4
3.99%
$163.58
+28.61% (+557,113)
2021 Q3
2.82%
$139.80
+2.19% (+41,743)
2021 Q2
2.90%
$134.93
+0.70% (+13,277)
2021 Q1
3.17%
$135.43
-14.23% (-313,790)
2020 Q4
3.96%
$139.14
+2.59% (+55,731)
2020 Q3
4.69%
$138.99
+14.04% (+264,778)
2020 Q2
3.94%
$119.57
-9.32% (-193,814)
2020 Q1
4.82%
$110.00
+29.21% (+470,065)
2019 Q4
4.32%
$124.90
+4.42% (+68,066)
2019 Q3
4.67%
$124.38
+16.75% (+221,102)
2019 Q2
3.68%
$109.65
+9.28% (+112,063)
2019 Q1
3.79%
$104.05
+51.19% (+408,966)
2018 Q4
3.31%
$91.92
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.